Keywords: UCB, Domainex, CDH technology, Cancer drug targets

UCB and Domainex elaborate on cancer drug target collaboration

Article | 12 March 2012

Print This

Belgian drugmaker UCB (Euronext Brussels: UCB) and Domainex, a UK-based drug discovery company, have jointly published the results of a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in